FDA Approves Keytruda as First Immune Checkpoint Inhibitor for Resectable Locally Advanced Head and Neck Cancer

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous cell…

Continue ReadingFDA Approves Keytruda as First Immune Checkpoint Inhibitor for Resectable Locally Advanced Head and Neck Cancer

Non-Surgical Root Canal Resolves Rare Mandibular Molar Malformation in Teenager: Case Report

Spain: In a recently published case report in the Journal of Endodontics, researchers from Spain have detailed the successful non-surgical management of a rare and complex dental anomaly—Dens Invaginatus (DI)—in…

Continue ReadingNon-Surgical Root Canal Resolves Rare Mandibular Molar Malformation in Teenager: Case Report

Vascular access status strongly linked with demoralization syndrome in Elderly maintenance hemodialysis Patients: Study

Researchers have found a strong correlation between vascular access status (VAS) and demoralization syndrome (DS) in elderly maintenance hemodialysis (MHD) patients in a new study. Further enhancing social support, managing…

Continue ReadingVascular access status strongly linked with demoralization syndrome in Elderly maintenance hemodialysis Patients: Study

Zibotentan–Dapagliflozin Combo Shows Promising Results in CKD Patients With and Without Diabetes: Study

Denmark: A recent post hoc analysis from the ZENITH-CKD trial suggests that combining zibotentan, a selective endothelin receptor antagonist, with dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, may offer consistent therapeutic…

Continue ReadingZibotentan–Dapagliflozin Combo Shows Promising Results in CKD Patients With and Without Diabetes: Study

Talc or Minocycline Pleurodesis May Aid managing malignant pleural effusion Management in Lung Cancer with ILD: Study

Researchers have found in a new study that Pleurodesis using talc or minocycline had potential as a treatment option for managing malignant pleural effusion (MPE) in patients with lung cancer…

Continue ReadingTalc or Minocycline Pleurodesis May Aid managing malignant pleural effusion Management in Lung Cancer with ILD: Study